Decoy Therapeutics Financials - Benzinga

Decoy Therapeutics Inc

DCOYNASDAQ

Trade with Public

Trade with Public

$3.10

0.5421.09%

al cierre: Sep 22, 5:00 PM EST

$3.26

0.165.29%

After hour: 4:50 PM EST

PRO

¿Por qué se mueve?:Decoy Therapeutics shares are trading higher after the company announced a ...

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Comparar Informe de acciones

Decoy Therapeutics Financials

Decoy Therapeutics (DCOY) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Decoy Therapeutics Q1 EPS $(4.18) Misses $(4.08) Estimate

Decoy Therapeutics (NASDAQ:DCOY) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(4.08) by 2.45 percent. This is a 98.26 percent increase over losses of $(240.07) per share

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved